Recruiting NA Correlation of Difficult Airway Markers With Ultrasonographic Measurements in Obese Patients

New treatment option for Correlation of Difficult Airway Markers With Ultrasonographic...

Official title Comparison of Airway Ultrasonography and Laryngoscopy Methods in Obese Patients

ClinicalTrials.gov ID: NCT07482436

What this study is testing

What it's testing
The main objective of this study was to examine the relationship between classical markers used in assessing difficult airway management in obese patients (Mallampati score, thyromental distance, sternomental distance, neck circumference measurement) and ultrasonographic parameters (vocal cord mobility, glottic opening, hyomental distance, skin-epiglottic distance, and peri-epiglottic space-epiglottic-vocal cord ratio), to compare the effects of these parameters on predicting difficult intubation, and to investigate the effects of different laryngoscopy methods on intubation success and peroperative respiratory complications. The secondary objective of the study is to investigate the effects of different laryngoscopy methods on hemodynamic responses to intubation.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • Patients who have given their consent
  • Patients who underwent surgery under general anesthesia
  • Patients over eighteen years of age
  • Patients with an American Society of Anesthesiologists (ASA) physical status classification of I-II-III
  • Patients with a body mass index (BMI) of 30 kg/m2 or higher

You likely can't join if

  • Patients who do not consent,
  • those undergoing head and neck surgery,
  • those to be operated on in the prone position,
  • uncooperative patients (patients with whom communication is not possible),
  • those with craniofacial anomalies,
  • patients operated on in emergency situations will be excluded from the study.
See the full eligibility criteria
Who can join
  • Patients who have given their consent
  • Patients who underwent surgery under general anesthesia
  • Patients over eighteen years of age
  • Patients with an American Society of Anesthesiologists (ASA) physical status classification of I-II-III
  • Patients with a body mass index (BMI) of 30 kg/m2 or higher
  • Patients whose surgery lasts between 60 and 150 minutes
  • Patients who underwent surgery under elective conditions will be included.
What rules you out
  • Patients who do not consent,
  • those undergoing head and neck surgery,
  • those to be operated on in the prone position,
  • uncooperative patients (patients with whom communication is not possible),
  • those with craniofacial anomalies,
  • patients operated on in emergency situations will be excluded from the study.

The study team makes the final eligibility decision.

Where it's taking place

  • Trabzon, Turkey (Türkiye)

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Trabzon, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.